• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Japan Pain Relief Medication Market

    ID: MRFR/HC/49333-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    Japan Pain Relief Medication Market Research Report By Medication Type (Non-Steroidal Anti-Inflammatory Drugs, Acetaminophen, Opioids, Adjuvant Analgesics), By Formulation Type (Tablets, Capsules, Liquid, Topical), By Route of Administration (Oral, Topical, Injectable, Transdermal) and By Therapeutic Area (Chronic Pain, Acute Pain, Postoperative Pain, Cancer Pain)-Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Japan Pain Relief Medication Market Research Report-Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Table of Contents

    Japan Pain Relief Medication Market Summary

    The Japan Pain Relief Medication market is projected to grow from 2.13 USD billion in 2024 to 3.12 USD billion by 2035.

    Key Market Trends & Highlights

    Japan Pain Relief Medication Key Trends and Highlights

    • The market is expected to achieve a compound annual growth rate of 3.53 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 3.12 USD billion, reflecting a steady increase in demand.
    • In 2024, the market is valued at 2.13 USD billion, indicating a robust foundation for future growth.
    • Growing adoption of innovative pain relief solutions due to an aging population is a major market driver.

    Market Size & Forecast

    2024 Market Size 2.13 (USD Billion)
    2035 Market Size 3.12 (USD Billion)
    CAGR (2025-2035) 3.53%

    Major Players

    Pfizer, Merck & Co., Eisai, Mitsubishi Tanabe Pharma, UCB, Takeda Pharmaceutical, Astellas Pharma, GlaxoSmithKline, Roche, Amgen, Bayer, Johnson & Johnson, AbbVie, Sanofi, Novartis

    Japan Pain Relief Medication Market Trends

    Changes in consumer behavior and improvements in healthcare have led to a number of noteworthy trends in the Japan Pain Relief Medication Market. The aging population in Japan is one of the main factors driving the market since it raises the incidence of chronic pain disorders. Because of this demographic shift, there is a greater need for efficient pain management products, especially for the treatment of arthritis and other age-related conditions. The expansion of the business is also supported by government measures to improve access to healthcare and pain treatment services.

    The creation of natural and non-pharmaceutical pain management solutions is becoming a more prominent area of commercial opportunity. Consumers' inclination for holistic treatments is in line with the growing interest in alternative therapies and traditional cures like herbal therapy and acupuncture. Japan is positioned as a promising market for integrative healthcare solutions due to the country's cultural preference for natural health products. New developments in digital health, such as telemedicine and pain management apps, have become more and more popular in recent years.

    Personalized care may now be provided remotely thanks to these developments, which is especially beneficial for people with mobility impairments. Further opportunities for product development are being created by the trend towards non-opioid alternatives as a result of growing awareness of the possible negative consequences of long-term usage of opioid drugs.There is a noticeable trend towards patient-centered care as the Japanese pain relief medication market develops, with a focus on safety, efficacy, and individualized treatment plans that cater to the particular requirements of the populace.

    This comprehensive strategy offers substantial market growth and innovation potential in addition to reflecting the evolving healthcare landscape.

    Japan Pain Relief Medication Market Drivers

    Market Segment Insights

    Japan Pain Relief Medication Market Segment Insights

    Japan Pain Relief Medication Market Segment Insights

    Pain Relief Medication Market Medication Type Insights

    Pain Relief Medication Market Medication Type Insights

    The Japan Pain Relief Medication Market has shown considerable segmentation within the Medication Type category, which reflects the diverse needs and preferences of patients dealing with pain management. Among these categories, Non-Steroidal Anti-Inflammatory Drugs are highly prevalent due to their effectiveness in reducing both inflammation and pain, making them a preferred choice for many individuals experiencing conditions like arthritis or acute injuries.

    Similarly, Acetaminophen ranks as one of the most commonly utilized pain relief options in Japan, particularly favored for its widespread availability and safety profile, which makes it suitable for various age groups.The Opioids segment, while holding significant importance due to their potent analgesic properties, has faced increased scrutiny and regulation in Japan due to concerns over potential dependency and misuse, prompting a shift towards alternative pain management therapies.

    Adjuvant Analgesics, which include medications typically used for other medical conditions but aid in pain relief, are gaining attention for their role in treating complex pain syndromes, thus highlighting the flexibility of treatment options available.

    The overall dynamics within the Medication Type segment reflect the evolving landscape of pain management in Japan, where patient safety, efficacy, and accessibility are key drivers of growth and development in the Japan Pain Relief Medication Market.With a growing elderly population and an increasing focus on chronic pain management, each of these segments plays a crucial role in addressing the healthcare needs of the population, underlining their relevance in the ongoing efforts to improve pain management strategies across the region.

    Pain Relief Medication Market Formulation Type Insights

    Pain Relief Medication Market Formulation Type Insights

    The Japan Pain Relief Medication Market is characterized by a diverse range of formulation types, each catering to different consumer needs and preferences. Tablets take a significant share, known for their convenience and longer shelf life, often favored by the population for chronic pain management. Capsules are also popular, offering easy ingestion and a controlled release of medication, which appeals to patients seeking effective pain relief with fewer gastrointestinal side effects. Liquid formulations are important for those who have difficulty swallowing pills, particularly the elderly demographic, thereby enhancing accessibility and compliance.

    Additionally, topical applications gain traction as they provide targeted relief with minimal systemic side effects, making them ideal for localized pain treatment. The increasing awareness of pain management options and the rising prevalence of chronic pain conditions in Japan are driving the demand for various formulations, reflecting the importance of tailored treatment strategies in the Japan Pain Relief Medication Market.

    This market segmentation is essential as it allows for the development of specific products that align with the needs of different consumer segments, ultimately fostering market growth and innovation in this industry.Overall, the formulation-type landscape illustrates a robust approach to pain relief, emphasizing customer-centric solutions.

    Pain Relief Medication Market Route of Administration Insights

    Pain Relief Medication Market Route of Administration Insights

    The Japan Pain Relief Medication Market, particularly in the Route of Administration segment, is crucial for understanding consumer preferences and market dynamics. Among these routes, the oral administration method is widely accepted due to its ease of use and effectiveness, making it a favored choice among patients. Topical applications are gaining traction as they provide localized relief with fewer systemic side effects, aligning with the growing demand for targeted pain management solutions. Injectable medications, while less commonly preferred, offer rapid relief for acute pain situations and are vital in clinical settings.

    Transdermal delivery systems are emerging prominently as they ensure sustained and controlled drug release, appealing to patients with chronic pain conditions who require consistent management. This segment of Japan's Pain Relief Medication Market is influenced by factors such as aging populations, increasing awareness of pain management options, and advancements in drug delivery technologies.

    As the market evolves, understanding these routes will be essential for stakeholders aiming to cater to Japan's unique healthcare needs, ensuring a well-rounded approach to pain relief solutions.The Japan Pain Relief Medication Market segmentation highlights a growing demand for diverse and effective delivery methods, reflecting broader industry trends toward personalized medication strategies.

    Pain Relief Medication Market Therapeutic Area Insights

    Pain Relief Medication Market Therapeutic Area Insights

    The Japan Pain Relief Medication Market, particularly within the Therapeutic Area segment, has shown significant evolution reflective of the country’s healthcare demands. Chronic Pain is a predominant concern, as many individuals suffer from conditions such as arthritis and back pain, necessitating ongoing medication for effective management. This segment holds a substantial portion of the market due to the aging population in Japan, where chronic conditions are prevalent. Acute Pain, often resulting from injury or surgery, remains vital in driving immediate treatment solutions, showcasing the importance of timely intervention and diverse medication options.

    Postoperative Pain management plays a critical role in recovery processes for surgical patients, emphasizing the need for effective medications to ensure patient comfort and facilitate healing. Moreover, Cancer Pain is significant as it requires specialized treatment plans to alleviate the suffering caused by malignant diseases, impacting a considerable patient demographic.

    The diverse requirements amongst these therapeutic areas reflect the market's complexity, and innovation in drug development continues to drive opportunities, catering to varied patient needs amid evolving healthcare paradigms in Japan.The Japan Pain Relief Medication Market segmentation is thus vital, illustrating a comprehensive picture of the diverse therapeutic needs within this critical industry.

    Get more detailed insights about Japan Pain Relief Medication Market Research Report-Forecast to 2035

    Request Free Sample

    Regional Insights

    Key Players and Competitive Insights

    The Japan Pain Relief Medication Market is characterized by a highly competitive landscape, driven by factors such as the aging population, increasing prevalence of chronic pain conditions, and growing awareness about pain management options among consumers. A variety of players operate within this market, offering a range of pain relief medications, including both over-the-counter (OTC) and prescription drugs. The competitive dynamics are influenced by multiple parameters such as product efficacy, pricing strategies, regulatory approvals, and marketing efforts. Companies are continuously striving to enhance their product portfolios while addressing the needs and preferences of healthcare professionals and patients alike.

    Innovation in formulations and targeted therapies is key to gaining market share in this mature yet evolving market.Pfizer has established a strong presence in the Japan Pain Relief Medication Market with its robust portfolio of both analgesics and non-steroidal anti-inflammatory drugs (NSAIDs). The company leverages its extensive research and development capabilities to introduce innovative pain relief solutions tailored to the specific needs of the Japanese consumer. Pfizer's strengths in this market include a well-recognized brand reputation, strong relationships with healthcare providers, and an effective distribution network, allowing for the widespread availability of its products across various retail and healthcare settings.

    The emphasis on developing evidence-based treatments has further solidified Pfizer's position as a trusted player in the realm of pain management in Japan.Merck & Co. also plays a significant role in the Japan Pain Relief Medication Market, with a diverse array of products aimed at managing different pain types. The company's key offerings include both prescription and OTC pain relief medications that cater to various patient demographics. Merck & Co. has established a solid market presence through strategic partnerships and collaborations that enhance its distribution capabilities.

    The company's strengths also lie in its commitment to research and innovation, allowing it to stay at the forefront of pain management treatments. Recent mergers and acquisitions have bolstered Merck's portfolio, enabling it to enhance its competitive positioning in Japan by expanding its therapeutic options and improving market accessibility. These strategic moves contribute to Merck & Co.'s ongoing efforts to address the evolving needs of patients and healthcare providers in the Japanese pain relief medication landscape.

    Key Companies in the Japan Pain Relief Medication Market market include

    Industry Developments

    In recent months, the Japan Pain Relief Medication Market has seen notable developments, particularly concerning major players like Pfizer, Merck and Co., Eisai, and Takeda Pharmaceutical. Notably, in August 2023, Pfizer unveiled advancements in its pain management portfolio, which includes innovative formulations aimed at chronic pain conditions widely experienced in Japan. Similarly, Takeda Pharmaceutical reported progress in its analgesic R&D efforts during a presentation in September 2023, demonstrating a growing commitment to addressing pain relief needs in the Japanese population.

    As part of market dynamics, Mitsubishi Tanabe Pharma has been expanding its product offerings, focusing on both prescription and over-the-counter pain relief solutions due to increasing demand. The Japanese government has also emphasized the importance of pain management guidelines to improve healthcare outcomes, further impacting the market landscape. While no significant mergers or acquisitions have taken place among the specified companies recently, the competitive landscape continues to evolve as companies like Roche and Amgen adapt their strategies to align with changing regulations and patient needs.

    Overall, these ongoing developments signal a proactive approach by companies within Japan's pain relief medication sector aimed at enhancing treatment options and improving patient care.

    Market Segmentation

    Outlook

    • Chronic Pain
    • Acute Pain
    • Postoperative Pain
    • Cancer Pain

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2023 2.05(USD Billion)
    MARKET SIZE 2024 2.13(USD Billion)
    MARKET SIZE 2035 3.12(USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 3.526% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Pfizer, Merck & Co., Eisai, Mitsubishi Tanabe Pharma, UCB, Takeda Pharmaceutical, Astellas Pharma, GlaxoSmithKline, Roche, Amgen, Bayer, Johnson & Johnson, AbbVie, Sanofi, Novartis
    SEGMENTS COVERED Medication Type, Formulation Type, Route of Administration, Therapeutic Area
    KEY MARKET OPPORTUNITIES Aging population increasing pain prevalence, Rising awareness of alternative therapies, Growth of e-commerce platforms, Innovations in drug formulations, Expansion in telemedicine services
    KEY MARKET DYNAMICS aging population, increasing chronic pain prevalence, rising healthcare expenditure, growing demand for OTC drugs, advancements in pain management therapies
    COUNTRIES COVERED Japan

    Market Highlights

    Author
    Rahul Gotadki
    Assistant Manager

    He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

    Get In Touch
    Leave a Comment

    FAQs

    What is the projected market size of the Japan Pain Relief Medication Market in 2024?

    The Japan Pain Relief Medication Market is expected to be valued at 2.13 billion USD in 2024.

    What is the expected market size of the Japan Pain Relief Medication Market by 2035?

    By 2035, the Japan Pain Relief Medication Market is projected to reach a value of 3.12 billion USD.

    What is the expected compound annual growth rate (CAGR) for the Japan Pain Relief Medication Market from 2025 to 2035?

    The expected CAGR for the Japan Pain Relief Medication Market from 2025 to 2035 is 3.526%.

    Which medication type has the largest market share in 2024 within the Japan Pain Relief Medication Market?

    The segment for Non-Steroidal Anti-Inflammatory Drugs is anticipated to have the largest market share at 0.85 billion USD in 2024.

    What market size is projected for the Acetaminophen segment by 2035?

    The Acetaminophen segment of the Japan Pain Relief Medication Market is expected to be valued at 0.78 billion USD by 2035.

    Who are the key players in the Japan Pain Relief Medication Market?

    Major players in the Japan Pain Relief Medication Market include Pfizer, Merck & Co., Eisai, and Takeda Pharmaceutical.

    What is the projected market size for Opioids in 2024?

    The Opioids segment of the market is expected to be valued at 0.43 billion USD in 2024.

    How much is the Adjuvant Analgesics market forecasted to be valued by 2035?

    The Adjuvant Analgesics segment is projected to reach a value of 0.49 billion USD by 2035.

    What are the key growth drivers for the Japan Pain Relief Medication Market?

    Key growth drivers include an aging population and increasing prevalence of chronic pain conditions.

    How are current market trends impacting the Japan Pain Relief Medication Market?

    Current trends towards personalized medicine and advancements in pain management technologies are positively influencing the market.

    1. EXECUTIVE SUMMARY
    2. Market Overview
    3. Key Findings
    4. Market Segmentation
    5. Competitive Landscape
    6. Challenges and Opportunities
    7. Future Outlook
    8. MARKET INTRODUCTION
    9. Definition
    10. Scope of the study
    11. Research Objective
    12. Assumption
    13. Limitations
    14. RESEARCH METHODOLOGY
    15. Overview
    16. Data Mining
    17. Secondary Research
    18. Primary Research
    19. Primary Interviews and Information Gathering Process
    20. Breakdown of Primary Respondents
    21. Forecasting Model
    22. Market Size Estimation
    23. Bottom-Up Approach
    24. Top-Down Approach
    25. Data Triangulation
    26. Validation
    27. MARKET DYNAMICS
    28. Overview
    29. Drivers
    30. Restraints
    31. Opportunities
    32. MARKET FACTOR ANALYSIS
    33. Value chain Analysis
    34. Porter's Five Forces Analysis
    35. Bargaining Power of Suppliers
    36. Bargaining Power of Buyers
    37. Threat of New Entrants
    38. Threat of Substitutes
    39. Intensity of Rivalry
    40. COVID-19 Impact Analysis
    41. Market Impact Analysis
    42. Regional Impact
    43. Opportunity and Threat Analysis
    44. Japan Pain Relief Medication Market, BY Medication Type (USD Billion)
    45. Non-Steroidal Anti-Inflammatory Drugs
    46. Acetaminophen
    47. Opioids
    48. Adjuvant Analgesics
    49. Japan Pain Relief Medication Market, BY Formulation Type (USD Billion)
    50. Capsules
    51. Liquid
    52. Topical
    53. Japan Pain Relief Medication Market, BY Route of Administration (USD Billion)
    54. Oral
    55. Topical
    56. Injectable
    57. Transdermal
    58. Japan Pain Relief Medication Market, BY Therapeutic Area (USD Billion)
    59. Chronic Pain
    60. Acute Pain
    61. Postoperative Pain
    62. Cancer Pain
    63. Competitive Landscape
    64. Overview
    65. Competitive Analysis
    66. Market share Analysis
    67. Major Growth Strategy in the Pain Relief Medication Market
    68. Competitive Benchmarking
    69. Leading Players in Terms of Number of Developments in the Pain Relief Medication Market
    70. Key developments and growth strategies
    71. New Product Launch/Service Deployment
    72. Merger & Acquisitions
    73. Joint Ventures
    74. Major Players Financial Matrix
    75. Sales and Operating Income
    76. Major Players R&D Expenditure. 2023
    77. Company Profiles
    78. Pfizer
    79. Financial Overview
    80. Products Offered
    81. Key Developments
    82. SWOT Analysis
    83. Key Strategies
    84. Merck & Co.
    85. Financial Overview
    86. Products Offered
    87. Key Developments
    88. SWOT Analysis
    89. Key Strategies
    90. Eisai
    91. Financial Overview
    92. Products Offered
    93. Key Developments
    94. SWOT Analysis
    95. Key Strategies
    96. Mitsubishi Tanabe Pharma
    97. Financial Overview
    98. Products Offered
    99. Key Developments
    100. SWOT Analysis
    101. Key Strategies
    102. UCB
    103. Financial Overview
    104. Products Offered
    105. Key Developments
    106. SWOT Analysis
    107. Key Strategies
    108. Takeda Pharmaceutical
    109. Financial Overview
    110. Products Offered
    111. Key Developments
    112. SWOT Analysis
    113. Key Strategies
    114. Astellas Pharma
    115. Financial Overview
    116. Products Offered
    117. Key Developments
    118. SWOT Analysis
    119. Key Strategies
    120. GlaxoSmithKline
    121. Financial Overview
    122. Products Offered
    123. Key Developments
    124. SWOT Analysis
    125. Key Strategies
    126. Roche
    127. Financial Overview
    128. Products Offered
    129. Key Developments
    130. SWOT Analysis
    131. Key Strategies
    132. Amgen
    133. Financial Overview
    134. Products Offered
    135. Key Developments
    136. SWOT Analysis
    137. Key Strategies
    138. Bayer
    139. Financial Overview
    140. Products Offered
    141. Key Developments
    142. SWOT Analysis
    143. Key Strategies
    144. Johnson & Johnson
    145. Financial Overview
    146. Products Offered
    147. Key Developments
    148. SWOT Analysis
    149. Key Strategies
    150. AbbVie
    151. Financial Overview
    152. Products Offered
    153. Key Developments
    154. SWOT Analysis
    155. Key Strategies
    156. Sanofi
    157. Financial Overview
    158. Products Offered
    159. Key Developments
    160. SWOT Analysis
    161. Key Strategies
    162. Novartis
    163. Financial Overview
    164. Products Offered
    165. Key Developments
    166. SWOT Analysis
    167. Key Strategies
    168. References
    169. Related Reports
    170. Japan Pain Relief Medication Market SIZE ESTIMATES & FORECAST, BY MEDICATION TYPE, 2019-2035 (USD Billions)
    171. Japan Pain Relief Medication Market SIZE ESTIMATES & FORECAST, BY FORMULATION TYPE, 2019-2035 (USD Billions)
    172. Japan Pain Relief Medication Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)
    173. Japan Pain Relief Medication Market SIZE ESTIMATES & FORECAST, BY THERAPEUTIC AREA, 2019-2035 (USD Billions)
    174. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    175. ACQUISITION/PARTNERSHIP
    176. MARKET SYNOPSIS
    177. JAPAN PAIN RELIEF MEDICATION MARKET ANALYSIS BY MEDICATION TYPE
    178. JAPAN PAIN RELIEF MEDICATION MARKET ANALYSIS BY FORMULATION TYPE
    179. JAPAN PAIN RELIEF MEDICATION MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
    180. JAPAN PAIN RELIEF MEDICATION MARKET ANALYSIS BY THERAPEUTIC AREA
    181. KEY BUYING CRITERIA OF PAIN RELIEF MEDICATION MARKET
    182. RESEARCH PROCESS OF MRFR
    183. DRO ANALYSIS OF PAIN RELIEF MEDICATION MARKET
    184. DRIVERS IMPACT ANALYSIS: PAIN RELIEF MEDICATION MARKET
    185. RESTRAINTS IMPACT ANALYSIS: PAIN RELIEF MEDICATION MARKET
    186. SUPPLY / VALUE CHAIN: PAIN RELIEF MEDICATION MARKET
    187. PAIN RELIEF MEDICATION MARKET, BY MEDICATION TYPE, 2025 (% SHARE)
    188. PAIN RELIEF MEDICATION MARKET, BY MEDICATION TYPE, 2019 TO 2035 (USD Billions)
    189. PAIN RELIEF MEDICATION MARKET, BY FORMULATION TYPE, 2025 (% SHARE)
    190. PAIN RELIEF MEDICATION MARKET, BY FORMULATION TYPE, 2019 TO 2035 (USD Billions)
    191. PAIN RELIEF MEDICATION MARKET, BY ROUTE OF ADMINISTRATION, 2025 (% SHARE)
    192. PAIN RELIEF MEDICATION MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2035 (USD Billions)
    193. PAIN RELIEF MEDICATION MARKET, BY THERAPEUTIC AREA, 2025 (% SHARE)
    194. PAIN RELIEF MEDICATION MARKET, BY THERAPEUTIC AREA, 2019 TO 2035 (USD Billions)
    195. BENCHMARKING OF MAJOR COMPETITORS

    Japan Pain Relief Medication Market Segmentation

    • Pain Relief Medication Market By Medication Type (USD Billion, 2019-2035)

      • Non-Steroidal Anti-Inflammatory Drugs
      • Acetaminophen
      • Opioids
      • Adjuvant Analgesics

     

    • Pain Relief Medication Market By Formulation Type (USD Billion, 2019-2035)

      • Tablets
      • Capsules
      • Liquid
      • Topical

     

    • Pain Relief Medication Market By Route of Administration (USD Billion, 2019-2035)

      • Oral
      • Topical
      • Injectable
      • Transdermal

     

    • Pain Relief Medication Market By Therapeutic Area (USD Billion, 2019-2035)

      • Chronic Pain
      • Acute Pain
      • Postoperative Pain
      • Cancer Pain
    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Related Reports

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027